weight management glp-1 Chart: 1 in 8 Americans Now Use Drugs for Loss GLP-1 Agonists Weight Loss Drugs

The Australia GLP-1 receptor agonist market size was valued at USD 570.49 million in 2025 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.

Risk of bias was assessed using an adapted Quality Assessment Tool for In Vitro Studies (QUIN) tool

Compounded Microdose GLP-1, flat $129/mo all-inclusive provider consultation, Rx, medication, and shipping

Explore the CDMO opportunities in the new Metabolic Economy today.

Learn how creatine and GLP-1 work together with NutraBios guide

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become essential medications in the management of type 2 diabetes mellitus and obesity due to their ability to improve glucose control and facilitate weight loss by enhancing insulin ...